公司資料
FEMASYS 股價、新聞與催化劑
- 股票代碼:
- FEMY
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
2.16 USD (-5.68%)
收盤價
最後更新: 2026年8月17日
22.4M USD
市值
股價為何變動
Following the latest company update, “Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update”, FEMY closed down 5.68% at $2.16 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
公司概覽
業務概覽
Femasys is a women’s health medical technology company focused on fertility and reproductive-health products. Its business is centered on procedures and devices that address unmet needs in women’s health.
所在地與產業分類
Femasys is headquartered in the United States and listed on NASDAQ. It sits in women’s-health medtech rather than biotechnology.
商業模式特徵
The company depends on product adoption, physician acceptance, and regulatory or commercial milestones. Investors watch launch execution, reimbursement, and the pace of market penetration.
生技產業定位
Femasys occupies a women’s-health device niche within healthcare innovation. It is not biotech proper, but its growth still depends on product adoption and clinical credibility.
未來催化劑
- Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most. The company needs to show the platform can translate into real clinical use.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。